Risks and Benefits of Drugs Used in the Management and Prevention of Gout
- 1 October 1994
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 11 (4), 252-258
- https://doi.org/10.2165/00002018-199411040-00004
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Nonsteroidal Anti-Inflammatory DrugsDrugs & Aging, 1994
- Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Drug Safety, 1993
- Desensitization to allopurinol in patients with gout and cutaneous reactionsAmerican Journal Of Medicine, 1992
- Treatment of gout and crystal arthropathies and uses and mechanisms of action of nonsteroidal anti-inflammatory drugsCurrent Opinion in Rheumatology, 1992
- What stops a gouty attack?1992
- Gout and hyperuricaemia.1987
- Asymptomatic hyperuricemia. Risks and consequences in the normative aging studyAmerican Journal Of Medicine, 1987
- Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiencyAmerican Journal Of Medicine, 1984
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981
- Allopurinol hepatotoxicityArthritis & Rheumatism, 1977